REAL-WORLD DATA (RWD) COHORT OF PATIENTS WITH ACUTE MYELOID LEUKEMIA (AML) IN THE UNITED STATES FROM AN ELECTRONIC HEALTH RECORD (EHR)–DERIVED DE-IDENTIFIED DATABASE

EHA Library, Evelyn Flahavan, 294518

REAL-WORLD TREATMENT PATTERNS, HEALTHCARE RESOURCE UTILIZATION, AND CLINICAL OUTCOMES FROM THE HUMANS STUDY IN MULTIPLE MYELOMA IN DENMARK, SWEDEN, AND FINLAND

EHA Library, Niels Abildgaard, 294519

VENETOCLAX ADDED TO CLADRIBINE, IDARUBICIN, AND CYTARABINE WITH OR WITHOUT A FLT3 INHIBITOR IN NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA

EHA Library, Tapan Kadia, 294520

MOLECULAR MINIMAL RESIDUAL DISEASE MONITORING IN NPM1-MUTATED ACUTE MYELOID LEUKEMIA: A SINGLE INSTITUTION EXPERIENCE.

EHA Library, Laura Cesini, 294521

RESULTS OF THE DOSE ESCALATION PART OF DIAMOND TRIAL (CLI24-001): FIRST IN HUMAN STUDY OF SEL24/MEN1703, A DUAL PIM/FLT3 KINASE INHIBITOR, IN PATIENTS WITH ACUTE MYELOID LEUKEMIA

EHA Library, Scott Solomon, 294522

ANALYSIS OF TREATMENTS AND OUTCOMES FOR PATIENTS WITH DE NOVO AML, THERAPY-RELATED AML AND SECONDARY AML (PRIOR MDS AND CMML) DIAGNOSED IN ENGLAND BETWEEN 2011–2016 USING HOSPITAL EPISODE STATISTICS©

EHA Library, Alex Legg, 294523

TEMPORAL TRENDS IN PRIMARY THERAPY AND RELATIVE SURVIVAL IN OLDER PATIENTS WITH ACUTE MYELOID LEUKEMIA: A POPULATION-BASED STUDY IN THE NETHERLANDS, 1989-2017

EHA Library, Avinash Dinmohamed, 294524

CPX-351 IS WELL TOLERATED, INDUCES A HIGH COMPLETE REMISSION RATE AND FACILITATES TRANSPLANT CONSOLIDATION IN POOR RISK ACUTE MYELOID LEUKEMIA PATIENTS: RESULTS FROM ITALIAN COMPASSIONATE USE PROGRAM

EHA Library, Fabio Guolo, 294525

ALDEHYDE DEHYDROGENASE GENETIC VARIANTS INFLUENCE THE RISK MYELODYSPLASTIC SYNDROMES AND ACUTE MYELOID LEUKEMIA DEVELOPMENT AND PROGRESSION

EHA Library, Ana Bela Sarmento-Ribeiro, 294526

SAFETY RUN-IN COHORT 1 OF GIMEMA AML1718: A SAFETY RUN-IN AND PHASE 2 OPEN-LABEL STUDY OF VENETOCLAX, FLUDARABINE, CYRATABINE AND IDARUBICINE (V-FLAI) IN INDUCTION THERAPY OF ACUTE MYELOID LEUKEMIA

EHA Library, Giovanni Marconi, 294527

THE WHO 2016 DIAGNOSTIC CRITERIA FOR ACUTE MYELOID LEUKEMIA WITH MYELODYSPLASIA RELATED CHANGES (AML-MRC) ARTIFICIALLY PRODUCE A HETEROGENOUS ENTITY

EHA Library, Julia Peters, 294528

INCIDENCE AND OUTCOME OF PATIENTS WITH RARE ACUTE PROMYELOCYTIC LEUKEMIA VARIANTS: THE PETHEMA-APL REGISTRY EXPERIENCE.

EHA Library, Marta Sobas, 294529

FINANCIAL IMPLICATIONS OF EARLY HOSPITAL DISCHARGE FOLLOWING INDUCTION CHEMOTHERAPY FOR ACUTE MYELOID LEUKEMIA: A RETROSPECTIVE ANALYSIS 2014-2018

EHA Library, Roland B. Walter, 294530

THE PRESENCE OF ADDITIONAL CHROMOSOMAL ABNORMALITIES IN PATIENTS AFFECTED BY ACUTE MYELOID LEUKEMIA WITH INV(16)(P13.1Q22) OR T(16;16)(P13.1;Q22);): MULTICENTRIC EXPERIENCE.

EHA Library, Silvia Imbergamo, 294531

RECOMBINANT THROMBOMODULIN REDUCES THE RISK OF DIFFERENTIATION SYNDROME AND ATRA RELATED SEVERE ADVERSE EVENTS DURING INDUCTION CHEMOTHERAPY FOR APL.

EHA Library, Norifumi Sugawara, 294532

FLUDARABINE, HIGH DOSE CYTARABINE AND IDARUBICIN-BASED INDUCTION OVERCOMES THE NEGATIVE PROGNOSTIC IMPACT OF FLT3-ITD MUTATION IN NPM1-MUTATED AML IRRESPECTIVELY OF FLT3-ITD ALLELIC BURDEN

EHA Library, Paola Minetto, 294533

CONDITIONAL RELATIVE SURVIVAL IN ADULT PATIENTS DIAGNOSED WITH ACUTE PROMYELOCYTIC LEUKEMIA IN THE NETHERLANDS: A POPULATION-BASED STUDY, 1989-2017

EHA Library, Avinash Dinmohamed, 294534

RISK FACTORS AND CLINICAL OUTCOMES OF AML PATIENTS WITH CENTRAL NERVOUS SYSTEM INVOLVEMENT

EHA Library, Georgina Stefania Daher, 294535

KINETICS OF BONE MARROW BLASTS AND USEFULNESS OF DAY 14 AND DAY 21 ASSESSMENT DURING INDUCTION OF ACUTE MYELOID LEUKEMIA

EHA Library, Zdenek Racil, 294536

GEMTUZUMAB OZOGAMICIN COMBINED WITH INTENSIVE CHEMOTHERAPY IN ACUTE MYELOID LEUKEMIA PATIENTS RELAPSING AFTER ALLOGENIC STEM-CELL TRANSPLANTATION

EHA Library, Alexis Genthon, 294537

PHARMACOKINETIC/PHARMACODYNAMIC EVALUATION OF IVOSIDENIB OR ENASIDENIB COMBINED WITH INTENSIVE INDUCTION AND CONSOLIDATION CHEMOTHERAPY IN PATIENTS WITH NEWLY DIAGNOSED IDH1/2-MUTANT AML

EHA Library, Yue Chen, 294538

HIGH RATE OF DURABLE REMISSIONS AFTER AUTOLOGOUS STEM CELL TRANSPLANTATION FOR CORE-BINDING FACTOR ACUTE MYELOID LEUKAEMIA IN SECOND COMPLETE REMISSION

EHA Library, Matthew James Rees, 294539

MOLECULAR/DIAGNOSTIC TESTING PATTERNS IN ELDERLY PATIENTS (PTS) WITH ACUTE MYELOID LEUKEMIA (AML) IN THE CONNECT® MDS/AML DISEASE REGISTRY

EHA Library, Tracy George, 294540

INTERMEDIATE-RISK ACUTE MYELOID LEUKEMIA TREATED WITH FLAI (FLUDARABINE, IDARUBICIN, CYTARABINE) INDUCTION: ANALYSIS OF FACTORS AFFECTING SURVIVAL AND EFFECT OF ALLOGENEIC STEM CELL TRANSPLANTATION.

EHA Library, Davide Lazzarotto, 294541

CD7 ABERRANT EXPRESSION IN ACUTE MYELOID LEUKEMIA IS AN INDEPENDENT MARKER OF POOR PROGNOSIS IN INTENSIVELY-TREATED PATIENTS

EHA Library, Joana Infante, 294542

IMPROVING OUTCOMES AND VALUE FOR PATIENTS OVER 60 WITH SECONDARY ACUTE MYELOID LEUKEMIA (S-AML) THROUGH INDUCTION WITH HIGH-DOSE MITOXANTRONE AND CYTARABINE (5+1)

EHA Library, Matthew Ulrickson, 294543

THE COMPARATIVE EFFECTIVENESS OF GLASDEGIB COMBINED WITH LOW-DOSE CYTARABINE VERSUS AZACITIDINE AMONG NEWLY-DIAGNOSED ACUTE MYELOID LEUKEMIA PATIENTS WHO ARE INELIGIBLE FOR INTENSIVE CHEMOTHERAPY

EHA Library, Sophie Van Beekhuizen, 294544

INTEGRATIVE STUDY OF EZH2 MUTATIONAL STATUS, COPY NUMBER, PROTEIN EXPRESSION AND H3K27 TRIMETHYLATION IN AML/MDS PATIENTS

EHA Library, Julia Stomper, 294545

IDENTIFICATION OF PML-RARA, CBFB-MYH11 AND RUNX1-RUNX1T1 GENOMIC FUSION SEQUENCES IS FEASIBLE AND ENABLES UNAMBIGUOUSLY INTERPRETABLE AND SENSITIVE MONITORING OF MINIMAL RESIDUAL DISEASE

EHA Library, Julius Lukes Jr., 294546

EVALUATING THE ROLE OF FLUORESCENCE IN SITU HYBRIDIZATION AS A SINGLE PROGNOSTIC MODALITY IN ACUTE MYELOID LEUKEMIA

EHA Library, Gal Sharvit, 294548

REAL-WORLD TREATMENT PATTERNS AND CLINICAL OUTCOMES IN UNFIT PATIENTS WITH AML RECEIVING FIRST LINE SYSTEMIC TREATMENT OR BEST SUPPORTIVE CARE (CURRENT): AN INTERIM ANALYSIS

EHA Library, Je-Hwan Lee, 294549

THERAPY-RELATED MYELOID NEOPLASMS CAN BE PREDICTED USING ROUTINE LABORATORY VALUES AND WITHOUT BONE MARROW BIOPSIES IN PATIENTS WITH CYTOPENIAS AFTER TREATMENT FOR BREAST CANCER

EHA Library, Giulia Petrone, 294550

EFFECT OF EARLY BLOOD COUNTS ON RESPONSE AND OVERALL SURVIVAL FOLLOWING GLASDEGIB PLUS LDAC IN NEWLY DIAGNOSED AML: BRIGHT AML 1003 POST HOC ANALYSIS.

EHA Library, Eunice Wang, 294551

CHARACTERIZATION OF CLINICAL PHARMACOKINETICS AND EXPOSURE-RESPONSE RELATIONSHIPS OF AMG 330, A BISPECIFIC CD33 T-CELL ENGAGER ANTIBODY CONSTRUCT, IN PATIENTS WITH RELAPSED/REFRACTORY AML

EHA Library, Suresh Agarwal, 294552

IS LESS MORE IN THE TREATMENT OF ELDERLY PATIENTS WITH ACUTE MYELOID LEUKEMIA? THE IMPACT OF THE INTRODUCTION OF CLINICAL TRIALS AT OUR INSTITUTION

EHA Library, Angel Serna, 294553

A FIRST IN HUMAN STUDY OF SEL120, A NOVEL ORAL SELECTIVE CDK8/19 INHIBITOR, IN PATIENTS WITH ACUTE MYELOID LEUKEMIA AND HIGH-RISK MYELODYSPLASTIC SYNDROME

EHA Library, Małgorzata Borowiak, 294554

MIDOSTAURIN IN COMBINATION WITH INTENSIVE CHEMOTHERAPY IN PATIENTS WITH FLT3-MUTATED ACUTE MYELOID LEUKEMIA (AML). A 'REAL LIFE' MULTI-CENTER EXPERIENCE FROM SPANISH TERTIARY HOSPITALS.

EHA Library, Mar Tormo, 294555

REAL-WORLD TOLERABILITY OF VENETOCLAX-BASED THERAPY IN COMBINATION WITH AZOLE ANTIFUNGAL THERAPY FOR ACUTE MYELOID LEUKAEMIA IN REMISSION

EHA Library, Ing Tiong, 294556

RESULTS OF A PILOT STUDY COMBINING CRENOLANIB WITH STANDARD SALVAGE CHEMOTHERAPY IN RELAPSED/REFRACTORY AML

EHA Library, Robert Collins, 294557

A EFFECTIVE TOOL FOR GERIATRIC ASSESSMENT IN ELDERLY ACUTE MYELOID LEUKEMIA PATIENTS: A MULTICENTER STUDY FROM CHINA

EHA Library, Chun-Li Zhang, 294558

A MODIFIED IA REGIMEN LEADS TO DECREASED MRD LEVELS AND A SURVIVAL ADVANTAGE FOR AML PATIENTS TRANSFORMED FROM MDS

EHA Library, Xueying Li, 294559

LOW-DOSE VENETOCLAX IS EFFECTIVE AND FREQUENTLY USED IN ADULTS WITH ACUTE MYELOID LEUKEMIA. A STUDY OF THE ACUTE LEUKEMIA WORKING GROUP (GTLA).

EHA Library, Andrés Gomez De León, 294560

GEMTUZUMAB OZOGAMICIN PLUS STANDARD CHEMOTHERAPY CARRIES A COMPARABLE BURDEN OF HOSPITALIZATION COMPARED WITH STANDARD CHEMOTHERAPY ALONE IN ACUTE MYELOID LEUKEMIA

EHA Library, Slaven Sikirica, 294561

SYNERGISTIC ANTI-LEUKEMIA EFFECT OF AZACITIDINE PLUS HOMOHARRINGTONINE AND THERAPEUTIC RESPONSE OF THE NOVEL COMBINATION-BASED REGIMENS IN ACUTE MYELOID LEUKEMIA WITH UNFAVORABLE OUTCOME

EHA Library, Zheng Ge, 294562

IMPACT OF LEUKOCYTAPHERESIS AND OTHER PARAMETERS ON EARLY 30-DAY MORTALITY IN PATIENTS WITH NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA PRESENTING WITH HYPERLEUKOCYTOSIS AND/OR LEUKOSTASIS

EHA Library, Ahmet Emre Eskazan, 294563

PROGNOSTIC RELEVANCE OF THE DIFFERENT PML-RARA VARIANT TRANSCRIPTS AND FLT3-ITD STATUS IN ADULTS WITH ACUTE PROMYELOCYTIC LEUKEMIA

EHA Library, Gueorgui Balatzenko, 294564

TUMOR LYSIS SYNDROME IN PATIENTS WITH ACUTE MYELOID LEUKEMIA TREATED WITH VENETOCLAX-CONTAINING REGIMENS

EHA Library, Rabia Shahswar, 294565

A NOVEL ONE STEP NGS ASSAY FOR ACCURATE DIAGNOSIS AND ULTRASENSITIVE MONITORING FOR DETECTION OF FLT3-ITD IN AML PATIENTS

EHA Library, Rakhi Salve, 294566

IMPACT OF BONE MARROW TREGS ON RESPONSE RATE AND SURVIVAL OF YOUNGER PATIENTS WITH NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA

EHA Library, Mario Delia, 294567

THROMBOSIS IN ACUTE MYELOID LEUKEMIA – WHO ARE THE HIGH RISK PATIENTS?

EHA Library, Mirjana Mitrovic, 294568

IMPACT OF SMALL EXTRACELLULAR VESICLES IN CHRONIC LYMPHOCYTIC LEUKAEMIA MICROENVIRONMENT

EHA Library, Ernesto Gargiulo, 294569

CD49D/CD29 CONTRIBUTES TO MURINE MARGINAL ZONE B CELL DEVELOPMENT IN SPLEEN AND TO LEUKEMIC INFILTRATION OF TCL1 TRANSGENIC MICE

EHA Library, Tanja Nicole Hartmann, 294570

COMBINATION OF EPIGENETIC DRUG SCREEN AND CRISPR KNOCKOUT SCREEN REVEALED INVOLVEMENT OF AURORA KINASES AND CULLIN 3 IN CD20 REGULATION

EHA Library, Aneta Ledererova, 294571

IBRUTINIB TREATMENT AFFECTS ΜRNA TRANSLATION IN CHRONIC LYMPHOCYTIC LEUKEMIA CELLS

EHA Library, Kostas Stamatopoulos, 294572

MECHANISM STUDY OF RESISTANCE TO THE TARGETED DRUG IBRUTINIB IN CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Hui Jin, 294573

GENOME-WIDE CRISPR/CAS9 SCREENING REVEALS NOVEL TARGET GENES, WHOSE INACTIVATION IS ABLE TO UPREGULATE SURFACE EXPRESSION OF IMMUNOTHERAPY TARGET CD20

EHA Library, Helena Peschelova, 294574

UTILIZATION OF NEXT GENERATION SEQUENCING TECHNOLOGY FOR EARLY DETECTION OF CHRONIC LYMPHOCYTIC LEUKEMIA UP TO 21 YEARS BEFORE DIAGNOSIS

EHA Library, Pieter Martijn Kolijn, 294575

T CELL RECEPTOR IMMUNOPROFILING IN SUBGROUPS OF CLL PATIENTS WITH DISTINCT GENOMIC ABERRATIONS

EHA Library, Elisavet Vlachonikola, 294576

INTERLABORATORY COMPARISON OF NGS METHODS FOR DETECTION OF TP53 VARIANTS <10% VAF: THE FIRST PHASE OF AN ERIC MULTICENTER STUDY ON THE CLINICAL IMPACT OF LOW-FREQUENT TP53 VARIANTS IN CLL

EHA Library, Sarka Pavlova, 294577

GSK3Β IS A CRITICAL COMPONENT OF THE SIGNALING NETWORK REGULATING NOTCH1 ACTIVATION IN CHRONIC LYMPHOCYTIC LEUKEMIA CELLS

EHA Library, Paolo Sportoletti, 294578

DEVELOPMENT OF A NOVEL PROGNOSTIC MODEL BASED ON M6A RNA METHYLATION REGULATORS IN CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Ya Zhang, 294579

MECHANISMS CONFERRING RESISTANCE TO VENETOCLAX IN CHRONIC LYMPHOCYTIC LEUKEMIA AND MANTLE CELL LYMPHOMA

EHA Library, Daniela Steinbrecher, 294580

TP53 ABERRANT CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS WITH INDOLENT CLINICAL COURSE EXHIBIT A DISTINCT IMMUNE SIGNALING TRANSCRIPTOMIC SIGNATURE

EHA Library, Kostas Stamatopoulos, 294581

IBRUTINIB ENHANCES MACROPHAGE-DEPENDENT THERAPY RESPONSES OF ANTIBODY COMBINATION THERAPY VIA JAK2 INHIBITION OF TARGET B-CELLS

EHA Library, Verena Barbarino, 294582

DISSECTING DIFFERENT ANATOMICAL COMPARTMENTS OF SMALL LYMPHOCYTIC LYMPHOMA WITH A LIQUID BIOPSY APPROACH

EHA Library, Riccardo Moia, 294583

MIR181A IS A NOVEL KEY PLAYER IN THE STAT3-MEDIATED SURVIVAL NETWORK IN TCRΑΒ CD8+ T-LGL LEUKEMIA

EHA Library, Jorn Assmann, 294584

COMPLEX KARYOTYPE IS ASSOCIATED WITH A LESS FAVORABLE OUTCOME AFTER IBRUTINIB AND RITUXIMAB AS FRONT-LINE TREATMENT OF UNFIT PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (GIMEMA LLC1114)

EHA Library, Ilaria Del Giudice, 294585

ROLE OF EPIGENETICS IN CHRONIC LYMPHOCYTIC LEUKEMIA PATHOGENESIS AND TREATMENT

EHA Library, Ana Bela Sarmento-Ribeiro, 294586

CONTRIBUTION OF ATM RARE GERMLINE VARIANTS TO GENETIC COMPLEXITY IN CLL

EHA Library, Anna Petráčková, 294587

TELOMERE LENGTH AND CD49D EXPRESSION COOPERATE WITH IGHV GENE STATUS AS PREDICTORS OF DURABLE PROGRESSION-FREE SURVIVAL IN CLL PATIENTS TREATED WITH FCR-BASED REGIMENS

EHA Library, Chris Pepper, 294588

EXPRESSION OF CD19 ANTIGEN ON CHRONIC LYMPHOCYTIC LEUKEMIA CELLS AFTER TAFASITAMAB (ANTI-CD19) TREATMENT: PHASE I TRIAL DATA

EHA Library, Rainer Boxhammer, 294589

QUANTIFICATION OF MINIMAL RESIDUAL DISEASE BY HIGH-THROUGHPUT SEQUENCING OF IGHV GENES IN CLL

EHA Library, Marine Dupont, 294590

COMPLEX KARYOTYPE IS A STRONG PREDICTOR OF SHORT-TERM PROGRESSION IN CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS TREATED WITH IBRUTINIB.

EHA Library, Tatiana Obukhova, 294591

PROLIFERATION AND UNMUTATED IGHV STATUS ARE ASSOCIATED WITH HOMOLOGOUS RECOMBINATION ACTIVITY IN CLL CELLS

EHA Library, Shai Shimony, 294592

LANDSCAPE OF LONG NON-CODING RNA AND ROLE OF LEF1-AS1 IN CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Lei Fan, 294593

HIGH THROUGHPUT SEQUENCING OF IGHV GENES REVEALS THE EXISTENCE OF RARE POLYCLONAL B CELLS WITH CLL TYPE STEREOTYPED BCR IN AGED HEALTHY PEOPLE

EHA Library, Marine Dupont, 294594

(SUB)CLONAL ARCHITECTURE AND TEMPORAL DYNAMICS OF THE T CELL RECEPTOR GENE REPERTOIRE IN PATIENTS WITH T-LGL PROLIFERATIONS

EHA Library, Jorn Assmann, 294596

GENE EXPRESSION IN CLL

EHA Library, Alexander Ring, 294597

PTBP1 REGULATES ALTERNATIVE SPLICING OF APOPTOTIC PROTEIN: IMPLICATIONS IN CLL AND IBRUTINIB RESISTANCE

EHA Library, Huayuan Zhu, 294598

ASSOCIATION BETWEEN EXPRESSION OF SLC28A3 GENE AND FLUDARABINE-INDUCED AUTOIMMUNE HEMOLYTIC ANEMIA IN CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS TREATED WITH FLUDARABINE-CYCLOPHOSPHAMIDE CHEMOTHERAPY

EHA Library, Vojin Vukovic, 294599

INDOLEAMINE-2,3-DIOXYGENASE (IDO) AS A NEW PLAYER IN THE CROSSTALK BETWEEN LEUKEMIC CELLS AND MICROENVIRONMENT IN CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Claudio Giacinto Atene, 294600

PREVALENCE, DISTRIBUTION AND PREDICTIVE VALUE OF XPO1 MUTATION IN CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Giulia Tueur, 294601

VARIANT ALLELE FREQUENCY OF 5% IS A SAFE AND ELIGIBLE REPORTING THRESHOLD FOR TP53 MUTATIONS DETECTED BY NEXT GENERATION SEQUENCING IN CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Panagiotis Baliakas, 294602

THE STUDY OF THE MOLECULAR MECHANISMS INDUCED BY NOTCH2 IN SPLENIC MARGINAL ZONE LYMPHOMA

EHA Library, Mylene Bun, 294603

BTK INHIBITOR THERAPY IS EFFECTIVE IN PATIENTS WITH CLL RESISTANT TO VENETOCLAX

EHA Library, Thomas Lew, 294604

PHASE 3B STUDY TO EVALUATE DEBULKING REGIMENS PRIOR TO INITIATING VENETOCLAX THERAPY IN UNTREATED PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Jeff P. Sharman, 294605

OBINUTUZUMAB AND VENETOCLAX IN UNTREATED UNFIT PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Mark-David Levin, 294606

LONG TERM RESULTS OF A PHASE I/IB STUDY OF IBRUTINIB IN COMBINATION WITH UMBRALISIB IN PATIENTS WITH RELAPSED/REFRACTORY CLL OR MCL

EHA Library, Matthew Davids, 294607

THE CHRONIC LYMPHOCYTIC LEUKEMIA-INTERNATIONAL PROGNOSTIC INDEX (CLL-IPI) CAN PREDICT OUTCOMES IN HIGH-COUNT MONOCLONAL B-CELL LYMPHOCYTOSIS AND RAI 0 CHRONIC LYMPHOCYTIC LEUKEMIA

EHA Library, Sameer Parikh, 294608

IMPACT OF PREMATURE VENETOCLAX (VEN) DISCONTINUATION/INTERRUPTION ON OUTCOMES IN RELAPSED/REFRACTORY (R/R) CHRONIC LYMPHOCYTIC LEUKEMIA (CLL): RESULTS FROM THE PHASE III MURANO STUDY

EHA Library, Anthony R. Mato, 294609

A PHASE IB STUDY OF SEQUENCE OF ADMINISTRATION OF IBRUTINIB PLUS OBINUTUZUMAB IN PATIENTS (PTS) WITH RELAPSED OR REFRACTORY (R/R) CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)

EHA Library, Matthew Davids, 294610

LATER TREATMENT AND EARLIER DIAGNOSIS OF DEL(17P) CLL AFTER INTRODUCTION OF TARGETED THERAPIES.

EHA Library, Christian Brieghel, 294611

EXTENDED FOLLOW-UP IN BIRC3-MUTATED RELAPSED/REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA (R/R CLL) PATIENTS TREATED WITH FIXED-DURATION VENETOCLAX PLUS RITUXIMAB: SUBGROUP ANALYSES OF THE MURANO TRIAL

EHA Library, Arnon P. Kater, 294612

CAUSE OF DEATH IN PATIENTS WITH NEWLY DIAGNOSED CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) STRATIFIED BY THE CLL-INTERNATIONAL PROGNOSTIC INDEX (CLL-IPI)

EHA Library, Yucai Wang, 294613

TUMOR MUTATIONAL LOAD DERIVED FROM RECURRENTLY MUTATED GENES IN CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) PREDICTS TIME-TO-FIRST TREATMENT IN HIGH-COUNT MONOCLONAL B CELL LYMPHOCYTOSIS (HC MBL)

EHA Library, Geffen Kleinstern, 294614

IGHV-ASSOCIATED METHYLATION CHANGES MORE ACCURATELY PREDICT CLINICAL OUTCOMES FOR CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS COMPARED TO IGHV MUTATION STATUS

EHA Library, Tomasz K. Wojdacz, 294615

SAFETY OF ACALABRUTINIB MONOTHERAPY IN MATURE B CELL MALIGNANCIES: POOLED ANALYSIS FROM CLINICAL TRIALS

EHA Library, Paolo Ghia, 294616

CHARACTERISTICS AND OUTCOME OF PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKAEMIA AND PARTIAL RESPONSE TO VENETOCLAX-OBINUTUZUMAB

EHA Library, Othman Al-Sawaf, 294617

T-GAMMA/DELTA LARGE GRANULAR LYMPHOCYTE LEUKEMIA IDENTIFIES A SUBSET OF PATIENTS WITH MORE SYMPTOMATIC DISEASE: ANALYSIS OF A COLLABORATIVE INTERNATIONAL COHORT OF 130 PATIENTS

EHA Library, Gregorio Barilà, 294618

IMPACT OF VENETOCLAX MONOTHERAPY ON THE QUALITY OF LIFE OF PATIENTS WITH RELAPSED OR REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA: RESULTS FROM VENICE II PHASE 3B TRIAL

EHA Library, Tara Cochrane, 294619